Retroscreen Virology Limited Purchases ALPHADAS for Clinical Studies Across Multiple Sites
7/31/2013 10:00:05 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that the operating subsidiary of Retroscreen Virology Group PLC (AIM: RVG, “Retroscreen”) has purchased the ALPHADAS® clinical trials software suite to assist in its mission to accelerate and reduce the cost of bringing anti-viral drugs, diagnostics, and vaccines to market.
Help employers find you! Check out all the jobs and post your resume.
comments powered by